R&D News | pharmaphorum

News

GSK bags breakthrough status for B7-H3 ADC for lung cancer

An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA.

News

US govt taps Walgreens for decentralised trials

Retail pharmacy giant Walgreens has signed a five-year contract with the US government – worth up to $100 million – for access to its decentralised clinical trials (DCT) network.

News

Pfizer and BioNTech's COVID/flu vaccine hits a hurdle

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight.

News

Pfizer grows digital team with chief AI officer appointment

Pfizer has appointed Berta Rodriguez-Hervas to its digital leadership team, naming her chief artificial intelligence and analytics officer.

News

Lykos co-founder Doblin to step down after MDMA setback

Lykos Therapeutics is slashing around 75% of its staff following the FDA's decision not to approve its MDMA-assisted therapy for post-traumatic stress disorder (PTSD) last week, with founde

News

Colourised transmission electron micrograph of mpox virus particles (red/yellow) found within infected VERO E6 cells (brown)

As WHO calls mpox emergency, NIH says only drug ineffective

The only antiviral recognised as an mpox treatment was unable to shorten the time to resolution of lesions in a trial in the Democratic Republic of the Congo (DRC), the epicentre of an outb

GSK bags breakthrough status for B7-H3 ADC for lung cancer

US govt taps Walgreens for decentralised trials

Pfizer and BioNTech's COVID/flu vaccine hits a hurdle

Pfizer grows digital team with chief AI officer appointment

Lykos co-founder Doblin to step down after MDMA setback

As WHO calls mpox emergency, NIH says only drug ineffective

UK's Claret Capital raises €575m for European biotechs

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks